Results 1 to 10 of about 3,296 (111)

Evaluating valaciclovir, letermovir, and maribavir safety in first-trimester human placental development [PDF]

Scientific Reports
Congenital cytomegalovirus (CMV) infection is the leading preventable cause of childhood disability, including sensorineural hearing loss and cerebral palsy in high-income countries.
Ishara Atukorala, Natasha de Alwis, Sally Beard, Swetha Raghavan, Natalie J. Hannan, Lisa Hui   +5 more
doaj   +2 more sources

Population pharmacokinetics and dose rationale for aciclovir in term and pre‐term neonates with herpes [PDF]

Pharmacology Research & Perspectives
Aciclovir is considered the first‐line treatment against Herpes simplex virus (HSV) infections in new‐borns and infants. As renal excretion is the major route of elimination, in renally‐impaired patients, aciclovir doses are adjusted according to the ...
S. D'Agate, D. Ruiz Gabarre, O. Della Pasqua   +2 more
doaj   +2 more sources

Acute tubulointerstitial nephritis following aciclovir treatment for chickenpox in children with nephrotic syndrome – a report of two cases

Central European Journal of Immunology, 2021
Tubulointerstitial nephritis (TIN) is an inflammatory process primarily involving the renal interstitium and is the cause of acute kidney injury (AKI) in 3-7% of cases confirmed by renal biopsy in children.
Małgorzata Pańczyk-Tomaszewska, Elżbieta Kuźma-Mroczkowska, Piotr Skrzypczyk, Hanna Szymanik-Grzelak, Jadwiga Małdyk   +4 more
doaj   +1 more source

Evaluation of Aciclovir-Induced Nephrotoxicity in Critically Ill Patients: A Propensity-Matched Cohort Study [PDF]

Journal of Clinical Medicine
René J Boosman, R J Bosman
exaly   +2 more sources

Queratitis epitelial por Virus Herpes Simplex

Ciencia & Salud, 2022
La queratitis herpética es la principal causa de ceguera infecciosa a nivel mundial, la principal etiología suele ser Virus Herpes Simplex tipo 1 (VHS-1). La exposición a VHS-1 a nivel mundial es sumamente común estimándose que aproximadamente un 90% de
Erika Quesada Jaikel, María Paz Castro González   +1 more
doaj   +1 more source

Insuficiencia renal aguda secundaria al tratamiento con Aciclovir por herpes zoster en pacientes con lupus eritematoso sistémico: reporte de dos casos

Enfermería Nefrológica, 2021
Se presentan dos casos de pacientes con lupus eritematoso sistémico con recidiva de herpes zoster, que desarrollan insuficiencia renal aguda secundaria al tratamiento con Aciclovir endovenoso. Descripción del plan de cuidados: el plan de cuidados estuvo
Marcos Reque, Emma Mariana Ábalos
doaj   +1 more source

Eficacia del ganciclovir tópico como alternativa terapéutica de la queratitis epitelial herpética

Revista Mexicana de Oftalmología, 2014
Objetivo: Comparar el uso del ganciclovir con el del aciclovir, usados de forma tópica, para la curación de la queratitis epitelial herpética en menos de 7 días.
Carlos Álvarez-Guzmán, Alejandro Rodríguez-García, Jaime Torres-Gómez   +2 more
doaj   +1 more source

A UHPLC–MS/MS Method for Therapeutic Drug Monitoring of Aciclovir and Ganciclovir in Plasma and Dried Plasma Spots

Biomedicines, 2021
The role of therapeutic drug monitoring (TDM) of valaciclovir (VA)/aciclovir (A) and valganciclovir/ganciclovir (VG/G) in critically ill patients is still a matter of debate.
Federica Pigliasco, Alessia Cafaro, Raffaele Simeoli, Sebastiano Barco, Alberto Magnasco, Maura Faraci, Gino Tripodi, Bianca Maria Goffredo, Giuliana Cangemi   +8 more
doaj   +1 more source

Cellulite abdominale : a propos d´un cas inhabituel

PAMJ Clinical Medicine, 2020
La varicelle est une affection considérée bénigne. Nous rapportons l´observation d´un garçon âgé de 2 ans et 2 mois qui se présente avec une fièvre chiffrée à 38oc et des éruptions érythématho-vesiculeuses d´âges différents évoluant depuis 7 jours ...
Mariam Moustapha Sylla, Karima El Fakiri, Rabiy EL Qadiry, Noureddine Rada, Ghizlane Draiss, Mohammed Bouskraoui   +5 more
doaj   +1 more source

A randomised controlled trial of the use of aciclovir and/or prednisolone for the early treatment of Bell’s palsy: the BELLS study

Health Technology Assessment, 2009
Objective: To determine whether oral prednisolone or aciclovir, used separately or in combination, early in the course of Bell’s palsy, improves the chances of recovery at 3 and 9 months. Design: A 2 × 2 factorial randomised double-blind trial.
FM Sullivan, IRC Swan, PT Donnan, JM Morrison, BH Smith, B McKinstry, RJ Davenport, LD Vale, JE Clarkson, R Hernández, K Stewart, V Hammersley, S Hayavi, A McAteer, D Gray, F Daly   +15 more
doaj   +1 more source